These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26114352)

  • 1. The impact of metabolic syndrome and hypertension on medical costs of patients with acute myocardial infarction at hospital.
    Fan GQ; Fu KL; Song M; Han L; Jin CW; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Exp Hypertens; 2015; 37(8):627-32. PubMed ID: 26114352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital.
    Fan GQ; Fu KL; Jin CW; Wang XZ; Han L; Wang H; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Interv Aging; 2015; 10():329-37. PubMed ID: 25670890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China.
    Yuan S; Liu Y; Li N; Zhang Y; Zhang Z; Tao J; Shi L; Quan H; Lu M; Ma J
    Pharmacoeconomics; 2014 Mar; 32(3):265-75. PubMed ID: 23975740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiologist service volume, percutaneous coronary intervention and hospital level in relation to medical costs and mortality in patients with acute myocardial infarction: a nationwide study.
    Liu CY; Lin YN; Lin CL; Chang YJ; Hsu YH; Tsai WC; Kao CH
    QJM; 2014 Jul; 107(7):557-64. PubMed ID: 24570479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents.
    Won KB; Kim BK; Chang HJ; Shin DH; Kim JS; Ko YG; Choi D; Ha JW; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):713-20. PubMed ID: 23934969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type 2 diabetes mellitus on hospitalization costs in older patients with acute myocardial infarction.
    Fu KL; Fan GQ; Han L; Wang XZ; Wang J; Wang YS; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Interv Aging; 2014; 9():711-8. PubMed ID: 24812498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011.
    Sugiyama T; Hasegawa K; Kobayashi Y; Takahashi O; Fukui T; Tsugawa Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001445. PubMed ID: 25801759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M
    Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of different revascularization strategies for patients with acute myocardial infarction with lesions of multiple coronary arteries after primary percutaneous coronary intervention and its economic evaluation].
    Zhang J; Wang Q; Yang H; Ma L; Fu X; Hou W; Feng J; Liu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Mar; 27(3):169-74. PubMed ID: 25757964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
    Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
    Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of the acute myocardial infarction guidelines on in-hospital managements and outcome of the patients in China].
    Li J; Jin ZN; Chen YD; Lu SZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):649-55. PubMed ID: 21122198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.
    Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2006; 7(1):7-11. PubMed ID: 16513517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study.
    Machecourt J; Bonnefoy E; Vanzetto G; Motreff P; Marlière S; Leizorovicz A; Allenet B; Lacroute JM; Cassagnes J; Touboul P
    J Am Coll Cardiol; 2005 Feb; 45(4):515-24. PubMed ID: 15708697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
    Bøhmer E; Kristiansen IS; Arnesen H; Halvorsen S
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary revascularization for acute myocardial infarction in the HIV population.
    Singh V; Mendirichaga R; Savani GT; Rodriguez AP; Dabas N; Munagala A; Alfonso CE; Cohen MG; Elmariah S; Palacios IF
    J Interv Cardiol; 2017 Oct; 30(5):405-414. PubMed ID: 28833489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK;
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.
    Wayangankar SA; Bangalore S; McCoy LA; Jneid H; Latif F; Karrowni W; Charitakis K; Feldman DN; Dakik HA; Mauri L; Peterson ED; Messenger J; Roe M; Mukherjee D; Klein A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):341-351. PubMed ID: 26803418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.